“…In addition to clinical assessment (history, examination, anteroposterior pelvic radiographs, and Oxford Hip Score questionnaire 23 ), all symptomatic patients underwent blood metal ion sampling and cross-sectional imaging. All asymptomatic patients who underwent total hip replacement and asymptomatic patients with BHR implants who had adverse reactions to metal debris risk factors (small femoral components, malpositioned acetabular components, radiographic evidence suggesting implant failure) underwent clinical assessment with blood metal ions 22,24,25 . In line with MHRA guidance, all asymptomatic patients with blood cobalt and/or chromium ion levels of >7 mg/L (the MHRA upper limit) underwent cross-sectional imaging 5 .…”